NNNN

Anbio Biotechnology Class A Ordinary Shares is a leading developer and distributor of innovative in vitro diagnostic (IVD) products, with a significant global presence across regions including the European Union, Asia Pacific, North America, South America, and Africa. Based in Frankfurt am Main, Germany, the company is dedicated to enhancing healthcare through state-of-the-art diagnostic solutions, positioning itself as a pivotal player in the biotechnology industry. With a comprehensive product portfolio and a commitment to research and development, Anbio is strategically poised for growth in the dynamic and expanding healthcare market.